---
figid: PMC12026460__ijms-26-03550-g001
figtitle: Mechanisms and Current Treatments of Cardiac Fibrosis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12026460
filename: ijms-26-03550-g001.jpg
figlink: /pmc/articles/PMC12026460/figure/F1/
number: F1
caption: Mechanisms and Current Treatments of Cardiac Fibrosis. This figure outlines
  the mechanisms, detection methods, and treatment strategies for cardiac fibrosis.
  miR-21 promotes fibrosis progression by regulating the transforming growth factor-beta
  (TGF-β) signaling pathway, while miR-29 regulates the metabolic balance of the extracellular
  matrix (ECM). Oxidative stress and inflammatory factors further exacerbate pathological
  changes. Magnetic Resonance Imaging (MRI) and serum biomarkers can be used to assess
  fibrosis. Biomarkers include procollagen type I N-terminal propeptide (PINP), procollagen
  type II N-terminal propeptide (PIINP), and matrix metalloproteinases (MMPs). Drugs
  such as Losartan, N-acetylcysteine (NAC), and regenerative medicine techniques provide
  potential therapeutic options. This figure was created in BioRender. Wang, Z. (2025).
  https://BioRender.com/n80e582, accessed on 7 April 2025
papertitle: 'From Skeletal Muscle to Myocardium: Molecular Mechanisms of Exercise-Induced
  Irisin Regulation of Cardiac Fibrosis'
reftext: Zhao Wang, et al. Int J Mol Sci. 2025 Apr;26(8).
year: '2025'
doi: 10.3390/ijms26083550
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: Irisin | exercise | cardiac fibrosis | cardioprotection
automl_pathway: 0.8777248
figid_alias: PMC12026460__F1
figtype: Figure
redirect_from: /figures/PMC12026460__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12026460__ijms-26-03550-g001.html
  '@type': Dataset
  description: Mechanisms and Current Treatments of Cardiac Fibrosis. This figure
    outlines the mechanisms, detection methods, and treatment strategies for cardiac
    fibrosis. miR-21 promotes fibrosis progression by regulating the transforming
    growth factor-beta (TGF-β) signaling pathway, while miR-29 regulates the metabolic
    balance of the extracellular matrix (ECM). Oxidative stress and inflammatory factors
    further exacerbate pathological changes. Magnetic Resonance Imaging (MRI) and
    serum biomarkers can be used to assess fibrosis. Biomarkers include procollagen
    type I N-terminal propeptide (PINP), procollagen type II N-terminal propeptide
    (PIINP), and matrix metalloproteinases (MMPs). Drugs such as Losartan, N-acetylcysteine
    (NAC), and regenerative medicine techniques provide potential therapeutic options.
    This figure was created in BioRender. Wang, Z. (2025). https://BioRender.com/n80e582,
    accessed on 7 April 2025
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - MIR21
  - XK
  - NLRP1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - CYREN
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - Losartan
  - NAC
  - ROS
---
